நிறுவனம் அல்லது கோர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவனம் அல்லது கோர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவனம் அல்லது கோர் Today - Breaking & Trending Today

Core One Labs Inc.: Core One Labs Provides Clarification on Trading Activity


Core One Labs Inc.: Core One Labs Provides Clarification on Trading Activity
Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62, WKN:A2P8K3) (the
Company or
Core One ). This news release is issued at the request of the Investment Industry Regulatory Organization of Canada (
IIROC ) and the Canadian Securities Exchange (
CSE ). Statements made in the news release issued by the Company on May 4, 2021 indicated that the Company had been made aware of potentially manipulative trading activity in its common shares. The news release issued on May 4, 2021 was not reviewed by IIROC or the CSE prior to dissemination, and to date the Company has not filed a formal complaint with any regulatory authority regarding this trading activity. ....

Province Of Ontario , British Columbia , Joel Shacker , While The Company , Company On , Core One Labs Inc , Investment Industry Regulatory Organization Of Canada , Health Canada , Company Or Core , Canadian Securities Exchange , Core One Labs , Investment Industry Regulatory Organization , Capital Markets Modernization Taskforce , Disclaimer Statement , Controlled Drugs , Substances Act , Core One , மாகாணம் ஆஃப் ஆஂடேரியொ , பிரிட்டிஷ் கொலம்பியா , ஜோயல் குலுக்கல் , போது தி நிறுவனம் , நிறுவனம் ஆன் , கோர் ஒன்று ஆய்வகங்கள் இன்க் , முதலீடு தொழில் ஒழுங்குமுறை ஆர்கநைஸேஶந் ஆஃப் கனடா , ஆரோக்கியம் கனடா , நிறுவனம் அல்லது கோர் ,

Core One Labs Provides Clarification on Trading Activity


Core One Labs Provides Clarification on Trading Activity
ACCESSWIRE
VANCOUVER, BC / ACCESSWIRE / May 21, 2021 /
Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62, WKN:A2P8K3) (the
Company or
Core One ). This news release is issued at the request of the Investment Industry Regulatory Organization of Canada (
IIROC ) and the Canadian Securities Exchange (
CSE ). Statements made in the news release issued by the Company on May 4, 2021 indicated that the Company had been made aware of potentially manipulative trading activity in its common shares. The news release issued on May 4, 2021 was not reviewed by IIROC or the CSE prior to dissemination, and to date the Company has not filed a formal complaint with any regulatory authority regarding this trading activity. ....

Province Of Ontario , British Columbia , Joel Shacker , While The Company , Company On , Core One Labs Inc , Investment Industry Regulatory Organization Of Canada , Health Canada , Company Or Core , Canadian Securities Exchange , Core One Labs , Core One , Investment Industry Regulatory Organization , Capital Markets Modernization Taskforce , Disclaimer Statement , Controlled Drugs , Substances Act , United States Wire Group , மாகாணம் ஆஃப் ஆஂடேரியொ , பிரிட்டிஷ் கொலம்பியா , ஜோயல் குலுக்கல் , போது தி நிறுவனம் , நிறுவனம் ஆன் , கோர் ஒன்று ஆய்வகங்கள் இன்க் , முதலீடு தொழில் ஒழுங்குமுறை ஆர்கநைஸேஶந் ஆஃப் கனடா , ஆரோக்கியம் கனடா ,

REPEAT - World Renowned Physician Joins Core One Labs as


Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “
Company” or “
Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“
Akome”), as Chief Medical Officer of the Company. Dr. Ferro will lead the Company through clinical trials and commercialization of its psychedelic products.
Dr. Ferro is a graduate of Javeriana University Medical School in his native Bogotá, Colombia, where he specialized in Internal Medicine, and received his sub-specialty training in Infectious Diseases at University of Toronto. Following completion of his medical and specialty training, Dr. Ferro returned to Bogotá and established a private practice in both Internal Medicine and Infectious Diseases, while at the same time held academic positions at different teaching hospitals. ....

United States , United Kingdom , New Jersey , British Columbia , Sanofi Pasteur , Smith Klein , Joel Shacker , Javeriana University Medical School , Clinical Team Leader , Colombian Infectious Disease Society , Core One Labs Inc , Infectious Disease Expert At Novartis Pharmaceuticals , Akome Biotech Ltd , Malaria Vaccine Initiative In Bethesda , Health Canada , Infectious Diseases At University Of Toronto , Canadian Securities Exchange , Company Or Core , Vp Clinical Affairs At Fio Corporation , One Labs , Santiago Ferro , Chief Executive Officer , Akome Biotech , Chief Medical Officer , Internal Medicine , Infectious Diseases ,